Fantastic 2 days in San Diego ๐ด
for the inaugural C8 Early Career Investigators Symposium.
Happy to represent #TeamManchester + connect with an inspiring group ๐.
A reminder that weโre not navigating academia alone - great to hear re: lessons learned & tips for future ๐ค.
@mcrcnews.bsky.social
#ESMOTAT26: Drug development in oncology is increasingly moving towards integrated strategies that consider tumour cells, their microenvironment and anatomical context.
Read the Opinion by Jon Lim, FRCP PhD in the #ESMODailyReporter ๐ https://ow.ly/fFUx50YJxOP
A collage of images show imaging technologies, stained cells and a mouse in a specially designed research habitat
๐จ Open for applications - Director of Scientific Core Facilities & Services!
Shape the strategic future of our core facilities and work with leading experts on cutting-edge cancer discovery and translational research ๐งโ๐ฌ๐ฌ๐งช
๐ท ~ยฃ100,000 โฐ 17.5.2026
Apply ๐ www.cruk.manchester.ac.uk/career/mi-26...
Tumour infiltrating lymphocyte (TIL) therapy is here to stay...but toxicity may be the real bottleneck.
Most of it is not the TILs - itโs everything around them. We unpack this in our latest review.
Available #OpenAccess - ๐ ๐๐ฎ๐ฎ๐ถ๐ฏ๐ฐ๐๐ฉ๐ฆ๐ณ ๐๐ข๐ฏ๐ค๐ฆ๐ณ @sitcancer.bsky.social๐
๐ jitc.bmj.com/content/14/4...
CRUK MI Director Samra Turaljic superimposed over an image of renal cell carcinoma cells stained with a fluorescenet dye.
We're thrilled to see our Director, Samra Turajliฤ be awarded the Kidney Cancer Association Pieter De Mulder award for contributions towards the treatment of kidney cancer ๐
Samra's research group is investigating how and why kidney cancer evolves to increase the success of treatment strategies ๐งช
๐ Weโre hiring: ๐ฅ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฃ๐ฟ๐ผ๐ท๐ฒ๐ฐ๐ ๐ ๐ฎ๐ป๐ฎ๐ด๐ฒ๐ฟ ๐ถ๐ป ๐๐บ๐บ๐๐ป๐ผ-๐ข๐ป๐ฐ๐ผ๐น๐ผ๐ด๐
An exciting ๐ role which sits at the heart of a highly collaborative & ambitious ecosystem spanning the Manchester Immuno-Oncology Network (MION) + the Advanced Immunotherapy and Cell Therapy (AICT) programme.
๐ฉ Deadline 9th April 2026.
Next, master of dendritic cells Caetano has an update on dead cell recognition in the context of tumor immunity:
We knew DC use exposed actin to gobble up dead cells. Here they show if you tether a model tumor antigen to actin, you get better anti-tumor immunity. Neat!!!
doi.org/10.1038/s415...
Cell therapy for solid tumours is advancing rapidly, but translation into patient benefit will depend on continued collaboration ๐.
๐ก Delighted to see this work come to fruition - thanks to all co-authors, for this thoughtful & collaborative effort.
@haanenjohn.bsky.social
#OpenAccess ๐
Exciting new research from our Group Leader @sylvaindelaunay.bsky.social and Pierre Close at @universitedeliege.bsky.social shows how modifying a tRNA can alter the immune profile of #melanoma - exposing it to the #ImmuneSystem
Read the full story here:
www.cruk.manchester.ac.uk/news/new-res...
We have three exciting opportunities for you to join us for a fully-funded 4-year #PhD project here in #Manchester starting in October 2026
Find full details of all the projects on our website: www.cruk.manchester.ac.uk/phd-student-...
Applications close 3rd April 2026
Just in time for our national TIL Therapy Summit in Manchester! We are pleased to share our perspective on the future of tumour-infiltrating lymphocyte (TIL) therapy.
Available open access via @springernature.com:
www.nature.com/articles/s41...
Fantastic inaugural national TIL Therapy Summit in Manchester with a stellar faculty โญ.
Great to welcome colleagues from across the UK & Europe for a day full of insightful discussions on the current landscape + future of TIL therapy.
@mcrcnews.bsky.social
Do you have an impactful research idea?
One that could improve care or advance science?
Apply for the ESMO Leadership & Career Development Award, offering protected research time, leadership & communication training by 3 May 26 .
๐https://ow.ly/Gicm50YqcbZ
#Oncology #ESMOYOC
The Crick Postdoctoral Clinical Fellowship has been one of the most pivotal steps in my development as a clinical academic.
The environment, mentorship, infrastructure, and scientific ambition at @crick.ac.uk are truly unparalleled.
Strongly recommended! Deadline: 30th April ๐
Grateful to ๐๐ณ ๐ ๐๐ข๐ฏ๐ค๐ฆ๐ณ for the kind feature in their ๐๐บ๐ฒ๐ฟ๐ด๐ถ๐ป๐ด ๐๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐ collection. Thank you to the editors for the nomination ๐.
Like many things, this really reflects teamwork & collaboration with many generous colleagues. Our perspective on TIL therapy in melanoma is now out #OpenAccess ๐
Man in a dark blue patterned shirt leaning on a window ledge inside a bright, modern corridor with large windows.
Professor Ludwig Dubois joins the MCRC & @manchester.ac.uk @fbmh-uom.bsky.social
as Chair in Experimental & Translational Radiobiology.
Heโll spearhead research into proton beam therapy & FLASH treatments to improve patient outcomes.
Read more: https://ow.ly/1k5g50YkUEn
Our new perspective just out in ๐๐ณ๐ช ๐ ๐๐ข๐ฏ๐ค๐ฆ๐ณ on TIL therapy in melanoma.
As TIL move closer to real-world use, the ๐ฉ๐ฐ๐ธ matters as much as the ๐ธ๐ฉ๐ฆ๐ต๐ฉ๐ฆ๐ณ. We reflect on the near future & the practical challenges of moving from trials to routine care.
Keen to hear thoughts/experiences from others๐
Come and join us at the ESMO Preceptorship on CUP! @worldcupalliance.bsky.social spread the word!
๐ New PhD Opportunity
An exciting PhD opportunity at the Cancer Research UK Manchester Centre, supporting the next generation of leaders in cancer research.
๐
Deadline: Friday 3 April
๐ For further information & to apply: ow.ly/ZWYs50Y7vHR
@uom-dcs.bsky.social
@manchester.ac.uk
๐...cutting-edge science, clinical insights & discussions re: real-world implementation of TIL therapy.
Featuring keynote speakers:
Inge Marie Svane ๐ฉ๐ฐ & Sebastian Klobuch ๐ณ๐ฑ.
@sklobuch.bsky.social
@debrajosephs.bsky.social
@turajliclab.bsky.social
@beckilee.bsky.social
๐ฃ Final agenda confirmed - only 5 weeks to go!
Join us on ๐ญ๐ญ ๐ ๐ฎ๐ฟ๐ฐ๐ต ๐ฎ๐ฌ๐ฎ๐ฒ in Manchester ๐ for our inaugural TIL Summit: Unlocking TIL Therapy โ A New Era for Melanoma Care in the UK.
Kindly sponsored by The Christie Charity.
Space limited - so don't miss out! For further information & to register:
One of the projects Iโm most proud of since returning to Manchester.
In awe of the resilience of our Ukrainian colleagues delivering cancer care under extraordinary circumstances, and grateful for the generosity of #TeamManchester colleagues in sharing best practice.
๐ฌ๐ง ๐ค ๐บ๐ฆ
Find out more ๐
New Journal for ImmunoTherapy of Cancer review: Steroid-sparing strategies for managing immune-related adverse events jitc.bmj.com/content/14/1...
lab to life
Exciting conference alert!
sites.manchester.ac.uk/from-lab-to-...
Fantastic speakers includingย Chris Marine, Christian Blank
Melanoma evolution
Local microenvironment of melanoma
Melanoma-host interactions
Precision immunotherapy
Emerging therapeutics
Clinical trials and real-world data
๐ For further details (deadline 3 June 2026):
www.esmo.org/meeting-cale...
๐ New on the ESMO events calendar for 2026!
Mark your calendar for the ๐๐ฆ๐ ๐ข ๐ฃ๐ฟ๐ฒ๐ฐ๐ฒ๐ฝ๐๐ผ๐ฟ๐๐ต๐ถ๐ฝ ๐ผ๐ป ๐ง๐๐บ๐ผ๐๐ฟ-๐๐ด๐ป๐ผ๐๐๐ถ๐ฐ ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ๐ ๐ฎ๐ป๐ฑ ๐๐ฎ๐ป๐ฐ๐ฒ๐ฟ ๐ผ๐ณ ๐จ๐ป๐ธ๐ป๐ผ๐๐ป ๐ฃ๐ฟ๐ถ๐บ๐ฎ๐ฟ๐ (๐๐จ๐ฃ) in Zurich: 18-19 September 2026.
Chaired by the fantastic @oncocook.bsky.social & @benwestphalen.bsky.social.
@myesmo.bsky.social
This is one of the projects Iโm most proud of since coming back to (re-)join #TeamManchester faculty. Delighted to welcome and host our Medical Oncology colleagues from UNCI, Kyiv at The Christie.
๐บ๐ฆ ๐ค ๐ฌ๐ง
Youโre such an inspiration, Adam! Keep going ๐.
๐ Kicking off the new year with our next #ChristieFellowship session!
How do we communicate science well - to patients, the public, and on social media?
Join us for an interactive session on ๐ฃ๐๐ฏ๐น๐ถ๐ฐ ๐๐ผ๐บ๐บ๐๐ป๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป with Prof @achoud72.bsky.social.
@christieinstitute.bsky.social
@mcrcnews.bsky.social
Thanks to @acir-org.bsky.social for highlighting our article!
